Elizabeth M Stone1, Alene Kennedy-Hendricks2, Colleen L Barry2, Marcus A Bachhuber3, Emma E McGinty2. 1. Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, United States; Johns Hopkins Center for Mental Health and Addiction Policy, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, United States. Electronic address: estone@jhu.edu. 2. Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, United States; Johns Hopkins Center for Mental Health and Addiction Policy, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, United States. 3. Section of Community and Population Medicine, Department of Medicine, Louisiana State University Health Sciences Center-New Orleans, 533 Bolivar Street, New Orleans, LA, 70112, United States.
Abstract
OBJECTIVES: To characterize primary care physicians' (PCPs) attitudes and beliefs about people with opioid use disorder (OUD) and to understand the association between PCPs' stigmatizing attitudes and their OUD treatment practices, beliefs about treatment effectiveness, and support for policies designed to improve access to OUD medications. METHODS: We conducted a national postal survey of U.S. PCPs from January to August 2019. Survey items measured respondents' attitudes, beliefs, and current treatment practices. Data were analyzed using descriptive statistics and logistic regression. RESULTS: Of the original 1000 PCPs in the survey sample, 668 were deemed eligible to participate in the study. The survey was completed by 361 PCPs for an adjusted response rate of 54 %. PCPs reported high levels of stigmatizing attitudes. Less than 30 % of PCPs reported that they were willing to have a person taking medication for OUD as a neighbor or marry into their family, even if that person was being treated with medication. Greater stigma was associated with an 11 percentage point lower likelihood that PCPs prescribed OUD medication and lower support for policies intended to increase access to OUD medication. CONCLUSIONS: Addressing OUD stigma among PCPs is a public health priority in addressing the ongoing opioid crisis.
OBJECTIVES: To characterize primary care physicians' (PCPs) attitudes and beliefs about people with opioid use disorder (OUD) and to understand the association between PCPs' stigmatizing attitudes and their OUD treatment practices, beliefs about treatment effectiveness, and support for policies designed to improve access to OUD medications. METHODS: We conducted a national postal survey of U.S. PCPs from January to August 2019. Survey items measured respondents' attitudes, beliefs, and current treatment practices. Data were analyzed using descriptive statistics and logistic regression. RESULTS: Of the original 1000 PCPs in the survey sample, 668 were deemed eligible to participate in the study. The survey was completed by 361 PCPs for an adjusted response rate of 54 %. PCPs reported high levels of stigmatizing attitudes. Less than 30 % of PCPs reported that they were willing to have a person taking medication for OUD as a neighbor or marry into their family, even if that person was being treated with medication. Greater stigma was associated with an 11 percentage point lower likelihood that PCPs prescribed OUD medication and lower support for policies intended to increase access to OUD medication. CONCLUSIONS: Addressing OUD stigma among PCPs is a public health priority in addressing the ongoing opioid crisis.
Authors: Anna P Goddu; Katie J O'Conor; Sophie Lanzkron; Mustapha O Saheed; Somnath Saha; Monica E Peek; Carlton Haywood; Mary Catherine Beach Journal: J Gen Intern Med Date: 2018-01-26 Impact factor: 5.128
Authors: Alene Kennedy-Hendricks; Susan H Busch; Emma E McGinty; Marcus A Bachhuber; Jeff Niederdeppe; Sarah E Gollust; Daniel W Webster; David A Fiellin; Colleen L Barry Journal: Drug Alcohol Depend Date: 2016-05-21 Impact factor: 4.492
Authors: Harold A Pollack; Margaret Pereyra; Carrigan L Parish; Stephen Abel; Shari Messinger; Richard Singer; Carol Kunzel; Barbara Greenberg; Barbara Gerbert; Michael Glick; Lisa R Metsch Journal: Am J Public Health Date: 2014-03-13 Impact factor: 9.308
Authors: Irineo Cabreros; Beth Ann Griffin; Brendan Saloner; Adam J Gordon; Rose Kerber; Bradley D Stein Journal: Drug Alcohol Depend Date: 2021-09-22 Impact factor: 4.492
Authors: Mathew V Kiang; Michael L Barnett; Sarah E Wakeman; Keith Humphreys; Alexander C Tsai Journal: Drug Alcohol Depend Date: 2021-09-24 Impact factor: 4.492
Authors: Christopher M Jones; Mamadou M Diallo; Meena Vythilingam; Joshua G Schier; Matthew Eisenstat; Wilson M Compton Journal: Drug Alcohol Depend Date: 2021-05-23 Impact factor: 4.852
Authors: Diego Vinicius Santinelli Pestana; Dante Raglione; Luiz Dalfior Junior; Caroline de Souza Pereira Liberatti; Elisangela Camargo Braga; Vitor Augusto de Lima Ezequiel; Adriana da Silva Alves; Juliana Gil Mauro; José Omar de Araújo Dias; Paulo Thadeu Fantinato Moreira; Bruno Del Bianco Madureira; Lilian Petroni Paiva; Bruno Melo Nóbrega de Lucena; João Manoel Silva Junior; Luiz Marcelo Sá Malbouisson Journal: PLoS One Date: 2022-02-10 Impact factor: 3.240
Authors: Alene Kennedy-Hendricks; Emma E McGinty; Amber Summers; Susan Krenn; Michael I Fingerhood; Colleen L Barry Journal: JAMA Netw Open Date: 2022-02-01